Neximmune Inc (NEXI)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Kristi Jones
Employees:
70
9119 GAITHER ROAD, GAITHERSBURG, MD, 20878
301-825-9810
Date | Ratio |
---|---|
2023-10-19 | 1:25 |
NexImmune, Inc. engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|